Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739104-24-000039
Filing Date
2024-11-07
Accepted
2024-11-07 09:07:58
Documents
78
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q FOR THE PERIOD ENDED SEPTEMBER 30, 2024 elan-20240930.htm   iXBRL 10-Q 1263207
2 EXHIBIT 31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex311elanco-20240930xceoce.htm EX-31.1 10285
3 EXHIBIT 31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER ex312elanco-20240930xcfoce.htm EX-31.2 10289
4 EXHIBIT 32 - CERTIFICATIONS OF CEO AND CFO ex32elanco-20240930xsectio.htm EX-32 8826
10 ELANCO LOGO elan-20240930_g1.jpg GRAPHIC 68307
  Complete submission text file 0001739104-24-000039.txt   6717598

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20240930.xsd EX-101.SCH 41955
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elan-20240930_cal.xml EX-101.CAL 65868
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elan-20240930_def.xml EX-101.DEF 258051
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20240930_lab.xml EX-101.LAB 564667
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20240930_pre.xml EX-101.PRE 421669
81 EXTRACTED XBRL INSTANCE DOCUMENT elan-20240930_htm.xml XML 879381
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

EIN.: 825497352 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38661 | Film No.: 241433458
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)